Predictive value of 99mTc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer

2002 ◽  
Vol 23 (8) ◽  
pp. 765-771 ◽  
Author(s):  
O. ALONSO ◽  
L. DELGADO ◽  
M. NÚÑEZ ◽  
C. VARGAS ◽  
J. LOPERA ◽  
...  
2004 ◽  
Vol 15 (2) ◽  
pp. 201-206 ◽  
Author(s):  
R. Colomer ◽  
A. Llombart-Cussac ◽  
A. Lluch ◽  
A. Barnadas ◽  
B. Ojeda ◽  
...  

The Breast ◽  
2015 ◽  
Vol 24 ◽  
pp. S68
Author(s):  
Tatiana Semiglazova ◽  
Petr Krivorotko ◽  
Ekaterina Busko ◽  
Sergey Novikov ◽  
Veronika Klimenko ◽  
...  

2020 ◽  
Vol 3 (3) ◽  
pp. 51-58
Author(s):  
Aldo Giovanno ◽  
Mgs. Irsan Saleh ◽  
Nur Qodir ◽  
Mulawan Umar

Breast cancer is a malignancy which invaded breast tissue in the form of ductal or lobular. One most therapywhich is given is neoadjuvant chemotherapy. Neoadjuvant Chemotherapy can reduce tumor size so that surgerycan be performed with good breast removal with Modification of Radical Mastectomy (MRM) and BreastConservative Therapy (BCT). This purpose from this research is to find out neoadjuvant chemotherapy response inLocally Advanced Breast Cancer Patients which has received chemotherapy treatment in RSUP dr MohammadHoesin Palembang. This observational descriptive study was conducted at RSUP Mohammad Hoesin Palembang inthe period between October until November 2019. The sample of this study was locally advanced breast Cancerpatients who underwent chemotherapy that met the inclusion and exclusion criteria. The data were obtained byinterviews and observed medical records from the patients which were then analyzed by univariate analysis usingSPSS version 25. In this study there were 34 locally advanced breast cancer patients who fulfilled the inclusion andexclusion criteria. 24 of 34 patients (70,6%) received positive response and 10 of 34 patients (29,4%) receivednegative response.


Sign in / Sign up

Export Citation Format

Share Document